Spur Therapeutics today announced that it will share updated clinical data from its Phase 1/2 GALILEO-1 trial of FLT201, its adeno-associated virus (AAV) gene therapy candidate for Gaucher disease ...

AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

Sometimes, you feel like you don't fit in simply because you haven't found your crew. Finding the right people who genuinely understand and appreciate you can take time. It's a journey of trial and ...

GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a ...

Stock analysts at Leerink Partnrs lifted their FY2024 EPS estimates for Ultragenyx Pharmaceutical in a report released on ...

Is BioMarin stock a bargain or a falling knife? Learn about key issues affecting its investment prospects and potential for recovery.

This article explores insights from Richmond-area therapists on Ketamine-Assisted Psychotherapy (KAP) and EMDR therapy, focusing on their applications in treating trauma, CPTSD, and mental health ...

The Delaware Symphony Orchestra (DSO) has chosen Brian Raphael Nabors as its 2025 A.I. duPont Composer's Award recipient.

A little-known arm of the National Institutes of Health (NIH) has directed over $1 billion into “sexual and gender minority” ...

Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) was the target of unusually large options trading activity on Tuesday. Stock traders acquired 6,905 put options on the stock. This represents ...

Scientists researching Alpine glaciers store ice in Antarctica. By analysing air bubbles in the ice they may be able to predict the future ...

Erica Hayes, 40, has not felt healthy since November 2020 when she first fell ill with covid. Hayes is too sick to work, so she has spent much of the last four years sitting on her beige couch, often ...